Dragon
LightNews LightNews
banner
dragonsky96.bsky.social
Dragon
@dragonsky96.bsky.social
830 followers 860 following 230 posts
She/Her pronouns. Artist and lover of books, nature, fantasy/sci-fi, dragon ball, etc. I mostly lurk and reblog posts that make me happy or that I feel are important (like information on climate change and social justice). 🚫 No GenAI or NFT 🚫
Posts Replies Media Videos
Reposted by Dragon
rami.spaceaustralia.com
Related:
science.org Science Magazine @science.org · 12h
Science’s 2024 Breakthrough of the Year was lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months.

Learn more about last year's #BOTY on #WorldAIDSDay: https://scim.ag/48pk7zZ
Science’s 2024 Breakthrough of the Year was lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months. The drug attaches to the lattice-like capsid proteins that shield the virus’s genetic material—a mechanism that could inspire other antivirals. Lenacapavir could help end the HIV/AIDS epidemic, but that will hinge on access for those who need it most.
December 1, 2025 at 7:06 PM
Reposted by Dragon
jon.gvg.io
Send feedback straight to them
bsky.app/profile/ryog...
ryogarocket.bsky.social Ryoga Rocket @ryogarocket.bsky.social · 1d
That I can do.

Search Prime Video for the title (I went with Banana Fish), then click on Details, and scroll past the Cast page to "Send Us Feedback."
A screenshot of Amazon Prime Video's page with the "Send us feeback" button as the focus
November 30, 2025 at 7:47 PM
dragonsky96.bsky.social
I am so sorry for your loss. 😔🩷
December 1, 2025 at 3:48 AM
dragonsky96.bsky.social
You did the safest and most humane thing. 😔 *hugs!*
November 30, 2025 at 6:27 AM
dragonsky96.bsky.social
That poor little bat! 🥺
November 30, 2025 at 4:18 AM
Reposted by Dragon
sailorrooscout.bsky.social
Their efficacy was confirmed against LIVE viruses including Ebola, Marburg, Nipah, Hendra, SARS-CoV, SARS-CoV-2 (COVID-19), AND Middle East Respiratory Syndrome (MERS).

The study has been published in Science Advances. YES, it is PEER-REVIEWED.
• www.science.org/doi/10.1126/...

🧪🧵⬇️
ABSTRACT Viral pandemics continue to threaten global health and economic stability. Despite medical advances, the absence of broad-spectrum antivirals (BSAs) prevents rapid responses to emerging viral threats. This is largely due to the lack of universal drug targets across diverse viral families and high variability among viral proteins. In this study, we evaluated 57 synthetic carbohydrate receptors (SCRs) for antiviral activity in cellulo using pseudotyped virus particles (PVPs) from six high-risk viruses across three families: Paramyxoviridae, Filoviridae, and Coronaviridae. Four SCRs inhibited all tested PVPs, and their efficacy was confirmed against live viruses including SARS-CoV-2, MERS-COV, EBOV, MARV, NiV, and HeV. Notably, SCR005 and SCR007, which exhibited minimal toxicity, significantly reduced SARS-CoV-2 infection in a severe animal model with a single dose. Mechanistic studies suggested that SCRs bind viral envelope N-glycans, blocking viral attachment and/or fusion. These results identify conserved viral N-glycans as promising BSA targets and establish SCRs as candidate prophylactic agents against enveloped viruses with pandemic potential.
November 28, 2025 at 5:02 PM